Local Dynamic Stability of Gait in People With Early Multiple Sclerosis and No-to-Mild Neurological Impairment.
Antonio Caronni, Elisa Gervasoni, Maurizio Ferrarin...
https://pubmed.ncbi.nlm.nih.gov/32356754/Actively Recruiting
Led by Istituto Auxologico Italiano · Updated on 2025-08-03
200
Participants Needed
2
Research Sites
N/A
Total Duration
This research aims to better understand balance and walking difficulties in people with rare, very rare, or undiagnosed neurological diseases. These conditions affect the nervous system and often cause progressive motor problems, increasing the risk of falls and injuries. Because these diseases are uncommon, little is known about their symptoms and progression, making diagnosis and treatment challenging. Participants will undergo questionnaires, clinical balance tests, and detailed instrumental assessments. These include self-reported balance and fatigue questionnaires, walking speed tests, mobility evaluations using wearable sensors, and treadmill walking with advanced motion capture. The study will also compare these impairments to those seen in more common neurological diseases like multiple sclerosis, Parkinsons disease, and peripheral neuropathy. During the study, participants will complete questionnaires and clinical scales, and their walking and balance will be measured with specialized equipment. Researchers will track various balance and gait parameters to identify unique patterns and progression over time. These detailed measurements will help understand the severity of impairments, support diagnosis, and guide future treatment and rehabilitation strategies. The study enrollment is open to adults aged 18 to 80 years, and participation may last several months or longer for follow-up assessments.
CONDITIONS
Gait and Balance Impairment in Rare and Very Rare Neurological Diseases
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
Istituto Auxologico Italiano
Lead Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Collaborating Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person) for eligibility assessment and informed consent
Duration - 1 day
Participants complete questionnaires, clinical scales, and instrumental tests to assess balance and gait.
1 visit (in-person) at enrollment
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
5
Have more questions? Get in touch with our team for quick support
Antonio Caronni, Elisa Gervasoni, Maurizio Ferrarin...
https://pubmed.ncbi.nlm.nih.gov/32356754/Stefano Scarano, Viviana Rota, Luigi Tesio...
https://pubmed.ncbi.nlm.nih.gov/35355583/Edgar R Vieira, Richard C Palmer, Paulo H M Chaves
https://pubmed.ncbi.nlm.nih.gov/27125497/Antonio Caronni, Irma Sterpi, Paola Antoniotti...
https://pubmed.ncbi.nlm.nih.gov/29413799/Michela Picardi, Valentina Redaelli, Paola Antoniotti...
https://pubmed.ncbi.nlm.nih.gov/32979787/Carola Reinhard, Anne-Catherine Bachoud-Lévi, Tobias Bäumer...
https://pubmed.ncbi.nlm.nih.gov/33519696/Stefano Scarano, Valeria Ada Sansone, Carola Rita Ferrari Aggradi...
https://pubmed.ncbi.nlm.nih.gov/35967003/The Lancet Neurology
https://pubmed.ncbi.nlm.nih.gov/21256450/David A Ganz, Yeran Bao, Paul G Shekelle...
https://pubmed.ncbi.nlm.nih.gov/17200478/Istituto Auxologico Italiano
Lead Sponsor
Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta
Collaborating Sponsor